Women should be educated on the risks and benefits of HRT, consider their personal risk, and be willing to take HRT, before starting treatment
In March 2026, a Foundayo is notable not only for its oral formulation but also for being among the first medications approved under the FDAs new Additionally, unlike other oral GLP-1s, it does not require the fasting and water restrictions associated with oral semaglutide, potentially making it more accessible
SURMOUNT-1 (N=2,539) tested 5 mg, 10 mg, and 15 mg weekly doses
Real-world hemoglobin A1c changes, prescribing provider types, and medication dose among patients with type 2 diabetes mellitus initiating treatment with oral semaglutide
Representation of molecules for drug response prediction